Quantcast

Organic Solvent Free Agarose LE from Universal Medical Inc.

February 24, 2011

Universal Medical Inc Teams up with Benchmark Scientific to Bring Laboratories an organic solvent free multi-purpose agarose.

Foxboro, MA (PRWEB) February 23, 2011

Benchmark Scientific uses a new process for manufacturing agarose that allows it to be produced without the use of any organic solvents. This new process yields a cleaner end product which reduces harmful impact on the environment.

This new agarose is highly purified with low electroendosmosis (EEO ⓰¤0.13 ““ mr) for increased electrophoretic mobility. This cleaner product has been specifically formulated for high gel strength and integrity. With exceptional thermal stability and mechanical resistance, it ensures safety and easy handling in the laboratory.

Researchers and Lab technicians will find Agarose LE suitable for a wide variety of electrophoresis applications. Not only has Benchmark Scientific produced this high quality product with little environmental impact but they have done it at a fraction of the cost. With agarose being one of the most commonly used products in the molecular biology lab this reduced cost will make every lab director happy. This is especially true today as laboratory budgets are getting squeezed from budget cuts due to the recession.

Universal Medical Inc offers the complete Benchmark Scientific product line including all 3 sizes of Agarose LE. Available in three different sized bottles. The electrophoresis agarose is available in 25g for those labs that want to try out a small sample of the product before switching from their current agarose supplier, 100g for medium sized laboratories, and 500g bottles for high volume molecular biology laboratories.

For more information on Agarose LE or to purchase Agarose LE you can contact Universal Medical Inc. at 800-423-2767 or visit http://www.UniversalMedicalInc.com/Agarose-s/567.htm

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/02/prweb5098254.htm


Source: prweb



comments powered by Disqus